Regadenoson
NDC 83032-001, Regadenoson, injection, solution, from Indies Pharma Jamaica Limited.
- Product NDC
- 83032-001
- Status
- Listed
- Labeler
- Indies Pharma Jamaica Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218054
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83032-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83032-001-02 | 83032000102 | 1 SYRINGE in 1 CARTON (83032-001-02) / 5 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/5095ab40-8503-46db-9b08-6a36f05fb5d9
Use it
Look up 83032-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83032-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83032-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.